Expression of concern

The Efficacy of the Novel Dual PI3-Kinase/mTOR Inhibitor NVP-BEZ235 Compared with Rapamycin in Renal Cell Carcinoma

Expression of concern Details

Nature of Retraction:

Expression of concern

Additional Notes:

David Panka has ORI finding of misconduct - see https://ori.hhs.gov/content/case-summary-panka-david;

Citations (177)

177
Total Citations
23
Post-Retraction
(13.0%)
134
Pre-Retraction
1
Same Day
Post-Retraction Citation Analysis
0 Within 30 days
4 Within 1 year
14 After 2+ years
2095 Days since retraction (latest)
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Feb 2018
515 days before retraction
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Nov 2017
581 days before retraction
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Nov 2017
594 days before retraction
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Nov 2017
607 days before retraction
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Sep 2017
668 days before retraction
Concurrent inhibition of mTORC1 and mTORC2 by WYE-687 inhibits renal cell carcinoma cell growth in vitro and in vivo
Xiaodong Pan, Donghua Gu, Jiahui Mao et al. (7 authors)
PLoS ONE Open Access
Published: Mar 2017
22 citations
850 days before retraction
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Oct 2016
979 days before retraction
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Sep 2016
1005 days before retraction
The Wide Experience of the Sequential Therapy for Patients with Metastatic Renal Cell Carcinoma
J. Lambea, Urbano Anido, Olatz Etxániz et al. (7 authors)
Current Oncology Reports
Published: Sep 2016
6 citations
1025 days before retraction
Novel drugs that target the metabolic reprogramming in renal cell cancer
Johannes C. van der Mijn, David J. Panka, Andrew K. Geissler et al. (5 authors)
Cancer & Metabolism Open Access
Published: Jul 2016
70 citations
1083 days before retraction
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Jun 2016
1116 days before retraction
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: May 2016
1138 days before retraction
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: May 2016
1147 days before retraction
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: May 2016
1153 days before retraction
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Mar 2016
1209 days before retraction
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Mar 2016
1215 days before retraction
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Jan 2016
1264 days before retraction
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Nov 2015
1328 days before retraction
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Nov 2015
1338 days before retraction
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Oct 2015
1358 days before retraction
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Sep 2015
1371 days before retraction
Hypoxia-Inducible Factor-1: A Critical Player in the Survival Strategy of Stressed Cells
Shuyang Chen, Nianli Sang
Journal of Cellular Biochemistry Open Access
Published: Jul 2015
109 citations
1439 days before retraction
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Jun 2015
1491 days before retraction
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: May 2015
1502 days before retraction
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: May 2015
1512 days before retraction
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Apr 2015
1537 days before retraction
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Apr 2015
1550 days before retraction
Paper citing Cyclin B1/Cdk1 Phosphorylation of Mitochondrial p5...
Unknown Authors
Unknown Journal
Published: Mar 2015
1559 days before retraction
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Feb 2015
1611 days before retraction
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Nov 2014
1694 days before retraction
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Nov 2014
1703 days before retraction
VHL and HIF in Clear Cell Renal Cell Carcinoma: Molecular Abnormalities and Potential Clinical Applications
Lucy Gossage
Springer eBooks
Published: Nov 2014
1703 days before retraction
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Sep 2014
1750 days before retraction
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Sep 2014
1763 days before retraction
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Aug 2014
1785 days before retraction
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Jun 2014
1831 days before retraction
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Jun 2014
1844 days before retraction
New Agents and New Targets for Renal Cell Carcinoma
George Philips, Michael B. Atkins
American Society of Clinical Oncology Educational Book Open Access
Published: May 2014
29 citations
1887 days before retraction
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Apr 2014
1901 days before retraction
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Apr 2014
1917 days before retraction
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Apr 2014
1917 days before retraction
PI3K/mTOR dual inhibitor NVP-BEZ235 decreases Mcl-1 expression and sensitizes ovarian carcinoma cells to Bcl-xL-targeting strategies, provided that Bim expression is induced
Abdelghani Jebahi, Marie Villedieu, Cécile Pétigny-Lechartier et al. (12 authors)
Cancer Letters Open Access
Published: Mar 2014
49 citations
1928 days before retraction
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Mar 2014
1936 days before retraction
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Mar 2014
1948 days before retraction
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Feb 2014
1973 days before retraction
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Feb 2014
1976 days before retraction
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Jan 2014
2007 days before retraction
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Dec 2013
2034 days before retraction
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Dec 2013
2037 days before retraction
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Nov 2013
2047 days before retraction
Quick Stats
Total Citations: 177
Years Since Retraction: 6.4 years
Open Access: Yes
Last Checked: Never
Related Papers
CD44 Expression Denotes a Subpopulation of Gastric Cancer C…
Clinical Cancer Research: An Official Journal of the American Association for Cancer Research • 181 citations
KMT2C Mutations in Diffuse-Type Gastric Adenocarcinoma Prom…
Clinical Cancer Research: An Official Journal of the American Association for Cancer Research • 79 citations
Tumor Escape from Endogenous, Extracellular Matrix-Associat…
Clinical Cancer Research: An Official Journal of the American Association for Cancer Research • 164 citations
Chemotherapy Resistance in Diffuse-Type Gastric Adenocarcin…
Clinical Cancer Research: An Official Journal of the American Association for Cancer Research • 96 citations